Suppliers / DSM Nutritional products

DSM Nutritional products

Germany Updated 9 July 2026

DSM Nutritional products is an API and finished-dose manufacturer based in Germany. It holds one active US drug master file across a filed portfolio of 6 molecules. Its filings concentrate with EEC_EAEU, MINSA (CR) and ARCSA (EC). Its GMP standing is certified by ANSM (FR), ZLG (DE) and EMA. Its most recent recorded inspection, by US FDA, closed on 15 December 2022 as NAI. Customs aggregates show $106K of exports covering 1 molecule to 1 destination in 2026 so far.

1
active US DMFs
0
valid CEPs
7
registered plants 1 with an FDA FEI number
21
filings across 4 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
2 of 2 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 15 December 2022 NAI US FDA
  • 2 February 2018 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Sisseln Ag, Switzerland Not on file
Baden-Wuerttemberg, Germany Not on file
Grenzach-Wyhlen, Germany Not on file
Germany, Germany 3004542694
VILLAGE NEUF, France Not on file
Village Neuf, France Not on file

1 further sites are on record.

What they file, and where

Molecule Regulators Docs
Cholecalciferol SFDA (Saudi Arabia), US FDA 3
Dexpanthenol SFDA (Saudi Arabia) 2
Ascorbic Acid SFDA (Saudi Arabia) 1
Cholecalciferol Vitamin D3 SFDA (Saudi Arabia) 1
Folic Acid SFDA (Saudi Arabia) 1
Phylloquinone SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
EEC_EAEU 12 None
MINSA (CR) 7 None
ARCSA (EC) 1 None
INVIMA (CO) 1 None
ANSM (FR) None 21
ZLG (DE) None 16
EMA None 4

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $106K 1

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about DSM Nutritional products

Does DSM Nutritional products hold a US DMF or a CEP?
DSM Nutritional products holds 1 active US drug master file. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is DSM Nutritional products FDA-registered?
One site operated by DSM Nutritional products carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did DSM Nutritional products's last inspection go?
The most recent inspection on record closed on 15 December 2022 as NAI (No Action Indicated: nothing objectionable was found). 2 inspections are on file.
Where does DSM Nutritional products manufacture?
7 registered sites are on record, in Switzerland, Germany, France and Mexico (Sisseln Ag, Baden-wuerttemberg and Grenzach-wyhlen among others). Every site is listed on this page with the register it came from.
What does DSM Nutritional products make?
6 molecules are on record against DSM Nutritional products, including Cholecalciferol, Dexpanthenol, Ascorbic Acid and Cholecalciferol Vitamin D3. Each links through to that molecule's full manufacturer list.
Which regulators recognise DSM Nutritional products's GMP?
Current GMP certificates are on record from ANSM (FR), ZLG (DE) and EMA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. DSM Nutritional products comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was NAI, on 15 December 2022.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts